Mercer, B M <br/><br/>
Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.  [electronic resource] 

 -  JAMA  Sep 1997 
 - 989-95 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0098-7484 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Amoxicillin--administration & dosage<br/>Ampicillin--administration & dosage<br/>Carrier State--drug therapy<br/>Double-Blind Method<br/>Drug Therapy, Combination--therapeutic use<br/>Erythromycin--administration & dosage<br/>Female<br/>Fetal Membranes, Premature Rupture--drug therapy<br/>Humans<br/>Infant, Newborn<br/>Infant, Premature<br/>Infant, Premature, Diseases--epidemiology<br/>Pregnancy<br/>Pregnancy Complications, Infectious--drug therapy<br/>Pregnancy Outcome<br/>Pregnancy Trimester, Second<br/>Pregnancy Trimester, Third<br/>Proportional Hazards Models<br/>Statistics, Nonparametric<br/>Streptococcal Infections--drug therapy<br/>Streptococcus agalactiae